NDC product
Bactoshield CHG
NDC 0116-0039 · Xttrium Laboratories, Inc.
Key facts
| Product NDC | 0116-0039 |
|---|---|
| Proprietary name | Bactoshield CHG |
| Nonproprietary name | Chlorhexidine Gluconate 4% |
| Substances | CHLORHEXIDINE GLUCONATE |
| Dosage form | SOLUTION |
| Route | TOPICAL |
| Labeler | Xttrium Laboratories, Inc. |
| Product type | HUMAN OTC DRUG |
| Marketing category | NDA |
| Application number | NDA019125 |
| Pharmacologic classes | Decreased Cell Wall Integrity [PE] |
| Marketing start | Nov 21, 2022 |
| Marketing end | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory